|
End-of-day quote
Taiwan S.E.
2026-10-01
|
5-day change | 1st Jan Change | ||
| 43.25 TWD | -0.12% |
|
+1.41% | -40.43% |
| 08-24 | SciVision Biotech's Joint Injections Get Medical Device Licenses in Panama | MT |
| 08-06 | SciVision Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 3.24B 101M 89.94M 84.11M 76.65M 144M 9.75B 146M 1.02B 394M 4.97B 380M 372M 15.95B | P/E 2024 |
31.5x | P/E 2025 | 33.3x |
|---|---|---|---|---|---|
| Enterprise Value | 2.8B 87.48M 77.7M 72.66M 66.21M 125M 8.42B 126M 879M 340M 4.29B 328M 321M 13.78B | EV / Sales 2024 |
7.79x | EV / Sales 2025 | 5.41x |
| Free-Float |
69.35% | Yield 2024 |
3.13% | Yield 2025 | 2.63% |
| 1 day | -0.12% | ||
| 1 week | +1.41% | ||
| Current month | -0.12% | ||
| 1 month | -8.17% | ||
| 3 months | -19.16% | ||
| 6 months | -27.19% | ||
| Current year | -40.43% |
| 1 week | 42.5 |  | 43.55 |
| 1 month | 42.25 | | 47.65 |
| Current year | 42.25 | | 87.5 |
| 1 year | 42.25 | | 111 |
| 3 years | 42.25 | | 144 |
| 5 years | 38.8 | | 144 |
| 10 years | 30.63 | | 144 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kai Cheng Han
CEO | Chief Executive Officer | - | 2002-06-13 |
Ju Ling Kuo
DFI | Director of Finance/CFO | - | 2003-07-27 |
Chun Nan Lin
DFI | Director of Finance/CFO | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Kai Cheng Han
CHM | Chairman | - | 2011-01-04 |
Tai Wei Han
BRD | Director/Board Member | - | 2006-10-31 |
| Director/Board Member | - | 2011-06-08 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.12% | +1.41% | -57.80% | -48.20% | 101M | |
| -2.17% | -4.33% | -27.56% | -0.17% | 167B | |
| +0.17% | -2.34% | -8.83% | +10.31% | 111B | |
| -0.88% | +1.19% | -25.04% | -0.11% | 105B | |
| +1.04% | +1.39% | -47.93% | -10.85% | 74.82B | |
| +3.17% | -0.03% | -0.64% | +72.13% | 59.11B | |
| -0.86% | +2.96% | +13.57% | +59.50% | 51.8B | |
| -0.52% | -0.65% | -6.74% | -31.12% | 48.5B | |
| -0.85% | +0.85% | -16.51% | +18.41% | 40.79B | |
| -0.07% | -1.42% | +30.49% | -7.58% | 32.54B | |
| Average | +0.48% | -0.08% | -14.70% | +6.23% | 69.03B | |
| Weighted average by Cap. | +0.48% | -0.91% | -16.14% | +9.60% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 883M 27.64M 24.55M 22.96M 20.92M 39.39M 2.66B 39.93M 278M 108M 1.36B 104M 102M 4.35B | 887M 27.74M 24.64M 23.04M 21M 39.53M 2.67B 40.08M 279M 108M 1.36B 104M 102M 4.37B |
| Net income | 242M 7.58M 6.73M 6.3M 5.74M 10.8M 730M 10.95M 76.17M 29.49M 372M 28.46M 27.84M 1.19B | 162M 5.08M 4.51M 4.22M 3.84M 7.24M 489M 7.34M 51.04M 19.76M 249M 19.07M 18.66M 800M |
| Net Debt | -582M -18.2M -16.17M -15.12M -13.78M -25.94M -1.75B -26.29M -183M -70.8M -892M -68.34M -66.85M -2.87B | -441M -13.79M -12.24M -11.45M -10.43M -19.64M -1.33B -19.91M -139M -53.62M -676M -51.76M -50.64M -2.17B |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-01 | NT$43.25 | -0.12% | 97,010 |
| 26-09-30 | NT$43.30 | +1.52% | 150,930 |
| 26-09-29 | NT$42.65 | 0.00% | 92,188 |
| 26-09-24 | NT$42.65 | -0.81% | 87,618 |
| 26-09-23 | NT$43.00 | +0.35% | 70,838 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 1786 Stock
Select your edition
All financial news and data tailored to specific country editions
